EUVIMEDEUVIMED entdecken
Crossref

Quality by Design‐Based Stability‐Indicating RP‐HPLC Method for Diminazene Diaceturate in Veterinary Formulation Supported by LC–MS Characterization of Degradation Products

Sumedha V Shetye iD, Archana S Gurjar iD

Biomedical Chromatography · 2026-05 · 40 (5)

DOI: 10.1002/bmc.70428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 16.03.2026. Verfasst von Sumedha V Shetye und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, Principal K. M. Kundnani College of Pharmacy, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Diminazene, Chromatography, Reverse-Phase, Liquid Chromatography-Mass Spectrometry, Veterinary Drugs. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study focuses on the development and validation of the Quality by Design RP‐HPLC method for diminazene diaceturate with fragmentation study by LC–MS/MS. The central composite design was employed to optimize critical factors: mobile phase ratio, flow rate, and wavelength. Analysis was conducted on Xterra C18 column with mobile phase composed of 0.1% triethylamine buffer: methanol (80:20% v/v) and flow rate 0.8 mL/min at 255 nm, with retention at 4.34 min. ICH Q1A(R2) guidelines, acid stress degradation study showed maximum degradation of 16.03%. The fragmentation pathway exhibited prominent product ions at m/z 518, 284, 285, and 268. Linearity was observed over the concentration range (50–100 μg/mL) with a regression coefficient of 0.9997. Limit of detection and limit of quantification values were observed to be 7.772 and 23.566 μg/mL, respectively; % RSD of each parameter was found to be less than 2. The validated method proved suitable for assay of marketed veterinary formulation, yielding recovery of 93.22%, with clear separation of the stabilizer phenazone. This study focuses on the development of a stability indicating RP‐HPLC method using a Quality by Design approach with LC–MS compatible triethylamine buffer, enabling degradation product characterization while maintaining a regulatory‐compliant RP‐HPLC method suitable for routine and stability testing of diminazene diaceturate in pharmaceutical laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiminazeneChromatography, Reverse-PhaseLiquid Chromatography-Mass SpectrometryVeterinary DrugsChromatography, High Pressure LiquidReproducibility of ResultsLinear ModelsDrug StabilityLimit of DetectionTandem Mass Spectrometry

Stichwörter der Autor:innen

RP‐HPLCquality by designstability study

Substanzen

Diminazenediminazene aceturateVeterinary Drugs

Autor:innen und Institutionen

  • Department of Pharmaceutical Analysis, Principal K. M. Kundnani College of Pharmacy, Mumbai, Maharashtra, India.

ORCID-Profile: Sumedha V Shetye, Archana S Gurjar

Zitieren

APA

Shetye, S. V., & Gurjar, A. S. (2026). Quality by Design‐Based Stability‐Indicating RP‐HPLC Method for Diminazene Diaceturate in Veterinary Formulation Supported by LC–MS Characterization of Degradation Products. Biomedical Chromatography, 40(5). https://doi.org/10.1002/bmc.70428

Vancouver

Shetye SV, Gurjar AS. Quality by Design‐Based Stability‐Indicating RP‐HPLC Method for Diminazene Diaceturate in Veterinary Formulation Supported by LC–MS Characterization of Degradation Products. Biomedical Chromatography. 2026;40(5). doi:10.1002/bmc.70428

BibTeX
@article{Shetye2026,
  author = {Shetye, Sumedha V and Gurjar, Archana S},
  title = {Quality by Design‐Based Stability‐Indicating RP‐HPLC Method for Diminazene Diaceturate in Veterinary Formulation Supported by LC–MS Characterization of Degradation Products},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {5},
  doi = {10.1002/bmc.70428}
}
Kostenlos starten →